NIH awards VeraChem Phase II SBIR funding for VM2 parallelization

January 1, 2011

Phase I milestones successfully completed, NIH awards VeraChem Phase II funding for the SBIR titled, “Multilevel Parallelization of Software for Accurate Protein-Ligand Affinities.”

About Us

VeraChem’s state of the art computational chemistry software is capable of protein-ligand and host-guest binding affinity prediction, fast calculation of accurate partial atomic charges for drug-like compounds, computation of energies and forces with empirical force fields, automatic generation of alternate resonance forms of drug-like compounds, conformational search with the powerful Tork distort-minimize algorithm, and automatic detection of topological and 3D molecular symmetries.

Privacy Policy

Products

Contact Info

VeraChem LLC
12850 Middlebrook Rd Ste 205
Germantown
MD 20874-5244

Voice: 240-686-0565
Fax: 240-686-0564

General e-mail:
vc@verachem.com

Commercial licensing:
sales@verachem.com

Customer support:
support@verachem.com

NIH awards VeraChem Phase II SBIR funding for VM2 parallelization

Recent Posts

Archives

About Us

Recent Posts

Products

Contact Info